ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,731.39
      0.01%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Aston Martin Np (AMLN)

      7. Aston Martin Np (AMLN) News

      AMLN

      Aston Martin Np (AMLN)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AMLN
      DateTimeSourceHeadlineSymbolCompany
      03/02/20127:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      03/02/20127:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/29/20128:00AMPR Newswire (US)Amylin Supports Rare Disease Day 2012NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/24/20125:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/24/20125:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/24/20125:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/24/20125:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/24/20125:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/24/20125:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/24/20125:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/24/20125:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/24/20125:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/24/20125:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/17/20127:53AMPR Newswire (US)CHMP Recommends Approval of BYETTA® for Use With Basal InsulinNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/16/20123:30AMZacksThe Zacks Analyst Blog Highlights: Charles Schwab, E*TRADE Financial, TD Ameritrade Holding, Amylin Pharmaceuticals & Alkerme..NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/15/201211:01AMZacksAmylin's Bydureon Launches in the US - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/14/201212:14PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/14/201210:43AMEdgar (US Regulatory)Schedule 13GNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/13/20128:10PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/13/20128:05PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/13/20128:00AMPR Newswire (US)BYDUREON™, First and Only Once-Weekly Type 2 Diabetes Treatment, Now Available in U.S. PharmaciesNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/10/20128:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/10/20128:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/10/20128:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/10/20128:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/10/20128:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/10/20128:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/10/20128:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/10/20128:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      02/10/20128:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
       Showing the most relevant articles for your search:NASDAQ:AMLN